Stay updated on Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded a new revision entry 'Revision: v3.3.2' and removed the previous 'Revision: v3.2.0' from the history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe general operating status notice at the top of the page has been removed. This change affects site-wide messaging rather than the study record details.SummaryDifference0.7%

- Check43 days agoChange DetectedOnly minor UI changes are visible (header/navigation and page chrome). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check50 days agoChange DetectedNew record history entries were added for Contacts/Locations and Study Status on 2025-10-24, with a prior update on 2025-10-22 (version 13). A deletion occurred on 2025-07-03.SummaryDifference0.5%

- Check71 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference12%

- Check79 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.3%

Stay in the know with updates to Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cagrilintide & Semaglutide in Type 2 Diabetes Clinical Trial page.